{
    "organizations": [],
    "uuid": "ed2ae90a5f38d4a25a23ae979392b05d58708dd9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncodna-signs-screening-collaborat/brief-oncodna-signs-screening-collaboration-with-kura-oncology-idUSFWN1ST0CO",
    "ord_in_thread": 0,
    "title": "BRIEF-OncoDNA Signs Screening Collaboration With Kura Oncology",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 22 (Reuters) - OncoDNA:\n* ONCODNA ANNOUNCES SCREENING COLLABORATION WITH KURA ONCOLOGY\n* ONCODNA SAYS CO TO SUPPORT PATIENT ENROLMENT FOR KURA ONCOLOGYâ€™S PHASE II TRIAL OF TIPIFARNIB\n* ONCODNA SAYS FINANCIAL TERMS OF AGREEMENT HAVE NOT BEEN DISCLOSED Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-22T19:14:00.000+03:00",
    "crawled": "2018-05-23T15:01:24.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "oncodna",
        "oncodna",
        "announces",
        "screening",
        "collaboration",
        "kura",
        "oncology",
        "oncodna",
        "say",
        "co",
        "support",
        "patient",
        "enrolment",
        "kura",
        "oncology",
        "phase",
        "ii",
        "trial",
        "tipifarnib",
        "oncodna",
        "say",
        "financial",
        "term",
        "agreement",
        "disclosed",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}